Edition:
India

People: Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

12.75USD
12 Aug 2020
Change (% chg)

-- (--)
Prev Close
$12.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
46,640
52-wk High
$18.87
52-wk Low
$5.65

Palleiko, Benjamin 

Mr. Benjamin (Ben) L. Palleiko serves as Chief Financial Officer, Chief Business Officer of the Company. Mr. Palleiko was appointed as our Chief Business Officer in addition to his role as Chief Financial Officer in March 2019. Prior to joining us, Mr. Palleiko was a Managing Director of H.C. Wainwright & Co. LLC since January 2015. He previously was Senior Vice President and Chief Financial Officer of Ore Pharmaceutical Holdings Inc. and Penwest Pharmaceuticals Co., and Chief Financial Officer of Nostrum Pharmaceuticals LLC. Earlier in his career Mr. Palleiko was an investment banker with the firms Robertson Stephens and SunTrust Bank. Mr. Palleiko holds a B.A. in Quantitative Economics from Tufts University and an M.B.A. in Finance and M.A. in International Relations from the University of Chicago. He served as a Naval Aviator in the U.S. Navy.

Basic Compensation

Total Annual Compensation, USD 558,150
Restricted Stock Award, USD 527,794
Long-Term Incentive Plans, USD --
All Other, USD 1,005,560
Fiscal Year Total, USD 2,091,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --